throbber
Bill.Zimmerman
`Horniak, David
`Bill.Zimmerman
`RE: Narcan Nasal Spray -- IPR Request
`Wednesday, November 06, 2019 1:58:50 PM
`
`From:
`To:
`Cc:
`Subject:
`Date:
`
`David:
`
`Thank you for your email.  The approach you outline below, using the default protective order, is
`acceptable to Indivior.  Please contact me if you run into any issues.
`
`Sincerely,
`Bill
`
`Bill Zimmerman
`Partner
`Bill.Zimmerman@knobbe.com
`202-640-6404 Direct
`Knobbe Martens
`1717 Pennsylvania Ave. N.W., Ste. 900
`Washington, D.C. 20006
`www.knobbe.com/bill-zimmerman
`
`From: Horniak, David <DHorniak@wc.com> 
`Sent: Wednesday, November 6, 2019 1:55 PM
`To: Bill.Zimmerman <Bill.Zimmerman@knobbe.com>
`Subject: RE: Narcan Nasal Spray -- IPR Request
`
`Hi Bill,
`
`Apologies for the delay in getting back to you.  We agree to Indivior’s restrictions, and thank you for
`your consideration and prompt response.  We have looked at the default PTAB protective order
`(which, as you probably know, is what the PTAB generally enters unless there is a good argument to
`do something different), and we believe it provides protections consistent with what you have
`described.  If Indivior documents are filed under seal, which is how we will submit them, then
`subsequent use of the documents will have to occur in sealed proceedings, not in an open hearing. 
`Accordingly, absent objection, we will proceed in this manner.  Thanks again.
`
`Best,
`
`David
`
`David Horniak
`Williams & Connolly LLP
`725 Twelfth Street, N.W., Washington, DC 20005
`(P) 202-434-5852 | (F) 202-434-5029
`
`Opiant Exhibit 2178
`Nalox-1 Pharmaceuticals, LLC v. Opiant Pharmaceuticals, Inc.
`IPR2019-00694
`Page 1
`
`

`

`dhorniak@wc.com | www.wc.com/dhorniak
` 
`From: Bill.Zimmerman <Bill.Zimmerman@knobbe.com> 
`Sent: Tuesday, October 22, 2019 3:02 PM
`To: Horniak, David <DHorniak@wc.com>
`Cc: Bill.Zimmerman <Bill.Zimmerman@knobbe.com>
`Subject: RE: Narcan Nasal Spray -- IPR Request
` 
`Dear David:
` 
`Thank you for your email.  Indivior will consent to the use of the documents attached to your email
`in the IPR proceedings, provided that the documents are submitted under seal pursuant to a
`protective order in the IPR proceedings, and provided that the documents are not shown on the
`screen in open PTAB proceedings, in the same way they were addressed in the district court
`litigation.  Please confirm that you agree to these restrictions.
` 
`Sincerely,
`Bill
` 
`Bill Zimmerman
`Partner
`Bill.Zimmerman@knobbe.com
`202-640-6404 Direct
`Knobbe Martens
`1717 Pennsylvania Ave. N.W., Ste. 900
`Washington, D.C. 20006
`www.knobbe.com/bill-zimmerman
` 
` 
` 
`From: Horniak, David <DHorniak@wc.com> 
`Sent: Tuesday, October 22, 2019 10:00 AM
`To: Bill.Zimmerman <Bill.Zimmerman@knobbe.com>
`Subject: Narcan Nasal Spray -- IPR Request
` 
`Hi Bill,
` 
`Thanks for speaking with me yesterday.  As you know, we represent Adapt Pharma in litigation
`involving the patents that cover Narcan® Nasal Spray.  Last year, Indivior produced 12 documents in
`response to a subpoena in litigation between our client and Teva.  A company called Nalox-1
`pharmaceuticals has now filed inter partes review petitions challenging Adapt’s patents, and the
`PTAB has instituted trial.  See IPR2019-00685, IPR2019-00688, and IPR2019-00694.  We would like
`Indivior’s permission to use a few of the documents it produced in the Teva case in the new inter
`partes review proceeding with Nalox-1. 
` 
`The documents we are seeking to use in the IPR are the same ones that Indivior authorized us to use
`at trial (and which we did use at trial) in the Teva matter.  I have attached them again for your
`
`Opiant Exhibit 2178
`Nalox-1 Pharmaceuticals, LLC v. Opiant Pharmaceuticals, Inc.
`IPR2019-00694
`Page 2
`
`

`

`reference.  If Indivior is amenable, we would be happy to request that the documents be submitted
`under seal subject to the PTAB’s form protective order. 
` 
`Please let me know if you have any questions, or if there is any other information I can provide that
`would be helpful.  I look forward to hearing from you.
` 
`Best,
` 
`David
` 
` 
`David Horniak
`Williams & Connolly LLP
`725 Twelfth Street, N.W., Washington, DC 20005
`(P) 202-434-5852 | (F) 202-434-5029
`dhorniak@wc.com | www.wc.com/dhorniak
` 
`
`
`This message and any attachments are intended only for the addressee and may contain information that is
`privileged and confidential. If you have received this message in error, please do not read, use, copy, distribute, or
`disclose the contents of the message and any attachments. Instead, please delete the message and any attachments
`and notify the sender immediately. Thank you.
`
`
`NOTICE: This email message is for the sole use of the intended recipient(s) and may contain confidential and
`privileged information. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not
`the intended recipient, please contact the sender by reply email and destroy all copies of the original
`message.
`
`NOTICE: This email message is for the sole use of the intended recipient(s) and may contain confidential and
`privileged information. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not
`the intended recipient, please contact the sender by reply email and destroy all copies of the original
`message.
`
`Opiant Exhibit 2178
`Nalox-1 Pharmaceuticals, LLC v. Opiant Pharmaceuticals, Inc.
`IPR2019-00694
`Page 3
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket